(Q36248450)

13 August 2017

Immunological evaluation and comparison of different EV71 vaccine candidates (English)

1 reference

13 August 2017

1 reference

Shih-Jen Liu

8

0 references

Chia-Chyi Liu

object named as

Chia-Chyi Liu

2

0 references

Jen-Ren Wang

object named as

Jen-Ren Wang

13

0 references

author name string

Ai-Hsiang Chou

1

1 reference

13 August 2017

Jui-Yuan Chang

3

1 reference

13 August 2017

Shu-Pei Lien

4

1 reference

13 August 2017

Meng-Shin Guo

5

1 reference

13 August 2017

Hau-Pong Tasi

6

1 reference

13 August 2017

Kuang-Nan Hsiao

7

1 reference

13 August 2017

Charles Sia

9

1 reference

13 August 2017

Suh-Chin Wu

10

1 reference

13 August 2017

Min-Shi Lee

11

1 reference

13 August 2017

Chia-Hsin Hsiao

12

1 reference

13 August 2017

Yen-Hung Chow

14

1 reference

13 August 2017

Pele Chong

15

1 reference

13 August 2017

12 September 2012

1 reference

Clinical and Developmental Immunology

13 August 2017

1 reference

13 August 2017

2012

1 reference

13 August 2017

831282

1 reference

Creative Commons Attribution 3.0 Unported

13 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Identification and characterization of a cross-neutralization epitope of Enterovirus 71.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Virus-like particles in vaccine development.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

EV71: an emerging infectious disease vaccine target in the Far East?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Development of enterovirus 71 vaccines.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

DNA vaccine constructs against enterovirus 71 elicit immune response in mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

An overview of the evolution of enterovirus 71 and its clinical and public health significance

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

An apparently new enterovirus isolated from patients with disease of the central nervous system

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447357

Enterovirus 71 vaccine: when will it be available?

29 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Combined peptides of human enterovirus 71 protect against virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F831282

Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides

21 January 2018

1 reference

12 December 2020

Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process

1 reference

12 December 2020

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

1 reference

12 December 2020

Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection

1 reference

12 December 2020

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

DOI

10.1155/2012/831282

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

23008736

1 reference